Naturhouse Health, S.A. (BME:NTH)
Spain · Delayed Price · Currency is EUR 2.540
0.00 (0.00%)
Aug 27, 2026, 5:35 PM CET
Naturhouse Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 47.63 | 49.43 | 50.41 | 52.4 | 57.59 | |
Revenue Growth | -3.63% | -1.95% | -3.81% | -9.01% | 4.56% |
Cost of Revenue | 13.55 | 14.15 | 13.9 | 15.16 | 16.58 |
Gross Profit | 34.08 | 35.28 | 36.51 | 37.24 | 41.01 |
Selling, General & Admin | 13.49 | 13.87 | 12.6 | 14.62 | 14.97 |
Other Operating Expenses | 6.22 | 6.32 | 5.37 | 7.48 | 6.05 |
Operating Expenses | 20.84 | 22.14 | 20.23 | 24.4 | 23.47 |
Operating Income | 13.24 | 13.14 | 16.28 | 12.84 | 17.54 |
Interest Expense | -0.09 | -0.6 | -0.62 | -0.21 | -0.1 |
Interest & Investment Income | 0.49 | 0.54 | 0.04 | 0.11 | 0.36 |
Earnings From Equity Investments | 0.18 | 0.47 | -0.15 | 0.31 | 0.59 |
Currency Exchange Gain (Loss) | -0.03 | -0.03 | -0.13 | 0.04 | 0.06 |
EBT Excluding Unusual Items | 13.8 | 13.53 | 15.43 | 13.09 | 18.45 |
Gain (Loss) on Sale of Assets | -0.11 | 0.01 | -0.01 | 0.01 | -0.21 |
Pretax Income | 13.7 | 13.54 | 15.42 | 13.1 | 18.25 |
Income Tax Expense | 3.6 | 3.68 | 4.17 | 3.48 | 4.88 |
Earnings From Continuing Operations | 10.09 | 9.86 | 11.25 | 9.62 | 13.37 |
Minority Interest in Earnings | - | - | 0.05 | 0.01 | -0.01 |
Net Income | 10.09 | 9.86 | 11.29 | 9.63 | 13.36 |
Net Income to Common | 10.09 | 9.86 | 11.29 | 9.63 | 13.36 |
Net Income Growth | 2.34% | -12.66% | 17.30% | -27.95% | 42.46% |
Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 60 |
Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 60 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 0.17 | 0.16 | 0.19 | 0.16 | 0.22 |
EPS (Diluted) | 0.17 | 0.16 | 0.19 | 0.16 | 0.22 |
EPS Growth | 5.23% | -15.06% | 17.73% | -27.27% | 40.62% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 11.67 | 11.22 | 20.38 | 6.13 | 16.12 |
Free Cash Flow Per Share | 0.20 | 0.19 | 0.34 | 0.10 | 0.27 |
Dividend Per Share | - | 0.200 | - | 0.150 | 0.200 |
Dividend Growth | - | - | - | -25.00% | 233.33% |
Gross Margin | 71.56% | 71.38% | 72.42% | 71.06% | 71.21% |
Operating Margin | 27.80% | 26.58% | 32.29% | 24.51% | 30.46% |
Profit Margin | 21.19% | 19.96% | 22.40% | 18.37% | 23.20% |
Free Cash Flow Margin | 24.51% | 22.70% | 40.43% | 11.70% | 27.99% |
EBITDA | 13.49 | 13.52 | 16.83 | 13.37 | 19.86 |
EBITDA Margin | 28.31% | 27.36% | 33.39% | 25.52% | 34.48% |
D&A For EBITDA | 0.24 | 0.39 | 0.55 | 0.53 | 2.31 |
EBIT | 13.24 | 13.14 | 16.28 | 12.84 | 17.54 |
EBIT Margin | 27.80% | 26.58% | 32.29% | 24.51% | 30.46% |
Effective Tax Rate | 26.29% | 27.17% | 27.04% | 26.59% | 26.74% |
Advertising Expenses | 3.02 | 3.38 | 2.67 | 3.5 | 3.93 |